Clinical outcomes after switch to mTOR inhibitors in kidney transplant recipients
Rev. colomb. nefrol. (En línea); 5 (1), 2018
Abstract Introduction: mTOR inhibitors Sirolimus and Everolimus are an alternative for inmunosuppression in renal transplant recipients. The aim of the study was to describe the experience of patients with switch to mTOR inhibitors, followed up for more than five years. Materials and methods: Patients ...